ALT - Altimmune - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALT is currently covered by 4 analysts with an average price target of $17.4. This is a potential upside of $12.88 (284.96%) from yesterday's end of day stock price of $4.52.

Altimmune's activity chart (see below) currently has 95 price targets and 93 ratings on display. The stock rating distribution of ALT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.53% with an average time for these price targets to be met of 31.91 days.

Highest price target for ALT is $18, Lowest price target is $12, average price target is $14.67.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 07-Nov-2025. First documented stock forecast 01-Jun-2020.

Currently out of the existing stock ratings of ALT, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Jul-2020

$14

$9.62 (219.63%)

$15

3 months 17 days ago
(07-Nov-2025)

0/16 (0%)

$9.89 (240.63%)

Buy Since 02-Jun-2021

$12

$7.62 (173.97%)

$12

4 months 4 days ago
(20-Oct-2025)

0/21 (0%)

$8 (200.00%)

Buy Since 25-Sep-2020

$18

$13.62 (310.96%)

$20

6 months 11 days ago
(13-Aug-2025)

4/17 (23.53%)

$14.26 (381.28%)

214

Buy Since 12-Nov-2024

$26

6 months 11 days ago
(13-Aug-2025)

0/1 (0%)

$16.51 (173.97%)

Buy Since 01-Jun-2020

$25

$20.62 (470.78%)

$25

1 years 8 months 3 days ago
(21-Jun-2024)

3/15 (20%)

$18.59 (290.02%)

42

Show more analysts

Please expand the browser size to see the chart

What is ALT (Altimmune) average time for price targets to be met?

On average it took 31.91 days on average for the stock forecasts to be realized with a an average price target met ratio 11.53

Which analyst has the current highest performing score on ALT (Altimmune) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on ALT (Altimmune)?

Mayank Mamtani works at B. RILEY and has 2 price targets and 2 ratings on ALT

Which analyst is the currently most bullish on ALT (Altimmune)?

Roger Song with highest potential upside - $30.62

Which analyst is the currently most reserved on ALT (Altimmune)?

Kelechi Chikere with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?